Figure 4
Serum markers of thrombo-inflammation in patients with dysglycemia and dyslipidemia at post-COVID-19 follow-up. COVID-19 patients were prospectively followed after acute COVID-19 and concentration of IL-6 (A, E), d-dimer (B, F), ferritin (C, G), and adiponectin (D, H) were prospectively assessed at 60, 100, 180, and 360 days after the onset of COVID-19. Subgroups are presented according to the presence of dysglycemia (A-D) or dyslipidemia (E–H), and statistical differences between these subgroups at each time point are indicated according to Mann Whitney-U tests *P < 0.05 and ***P < 0.001. Points depict means, error bars indicate standard error (SE). N60days = 145, N100days = 138, N180days = 119, N360days = 92.
